Pharmaceutical success no longer ends with approval. Post-market evidence now shapes formulary decisions, safety monitoring, and even label expansion.

RWE provides insights from the real world—outside the trial bubble. At ClineEpi Partners, we support clients through the design and execution of RWE studies that align with regulatory, payer, and clinical expectations.

From retrospective cohort analyses to hybrid designs, we bring statistical rigor and real-world context together to produce results that matter.